Conference Proceedings

Long-Term Safety And Efficacy Of Add-On Cannabidiol (CBD) Treatment In Patients With Dravet Syndrome In An Open-Label Extension Trial (GWPCARE5)

R Nabbout, J Halford, IE Scheffer, R Sanchez-Carpintero, Y Shiloh Malawsky, M Wong, D Checketts, K VanLandingham

EPILEPSIA | WILEY | Published : 2019

University of Melbourne Researchers


Funding Acknowledgements

GW Research Ltd, Cambridge, UK.